Blood biochemical parameters for assessment of COVID-19 in diabetic and non-diabetic subjects: a cross-sectional study.
Syeda Umme Fahmida MalikParveen Afroz ChowdhuryAl HakimMohammad Shahidul IslamMd Jahangir AlamAbul Kalam AzadPublished in: International journal of environmental health research (2021)
This study aims to identify blood biomarkers for rapidly predicting progression and severity assessment of COVID-19 in type 2 diabetic (DM) and non-DM (NDM) patients. Among 211 hospitalized patients suspected of COVID-19, 98 were confirmed COVID-19 by rRT-PCR. The COVID-19 positive group contained 58 DM and 40 NDM patients with total death 9 of which 7 were males and 6 were DM, indicating males and DM individuals as more susceptible to COVID-19. Blood biomarkers notably serum ferritin, CRP, D-dimer, ALT, troponin I, and Hb1Ac were significantly (p < 0.05) higher in COVID-19 patients. Ferritin and HbA1c levels were significantly (p < 0.05) higher in DM than NDM COVID-19 patients. The present study suggests that ferritin and HbA1c levels for DM patients, and ferritin, D-dimer, ALT for NDM patients could be routinely used as biomarkers for progression and severity assessment of COVID-19. CRP and Troponin-I could be the predictor only for poor prognosis of COVID-19.
Keyphrases
- sars cov
- coronavirus disease
- end stage renal disease
- poor prognosis
- ejection fraction
- chronic kidney disease
- type diabetes
- respiratory syndrome coronavirus
- prognostic factors
- long non coding rna
- klebsiella pneumoniae
- metabolic syndrome
- escherichia coli
- adipose tissue
- patient reported outcomes
- skeletal muscle
- wound healing
- iron deficiency